JPH03210193A - Measuring instrument for hydrolase - Google Patents
Measuring instrument for hydrolaseInfo
- Publication number
- JPH03210193A JPH03210193A JP345690A JP345690A JPH03210193A JP H03210193 A JPH03210193 A JP H03210193A JP 345690 A JP345690 A JP 345690A JP 345690 A JP345690 A JP 345690A JP H03210193 A JPH03210193 A JP H03210193A
- Authority
- JP
- Japan
- Prior art keywords
- group
- measuring instrument
- oxidizing agent
- hydrolase
- ester compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 phenoxy ester compound Chemical class 0.000 claims abstract description 26
- 239000007800 oxidant agent Substances 0.000 claims abstract description 15
- 125000005843 halogen group Chemical group 0.000 claims abstract description 11
- 125000000539 amino acid group Chemical group 0.000 claims abstract description 9
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 7
- 239000003463 adsorbent Substances 0.000 claims abstract description 6
- 239000004744 fabric Substances 0.000 claims abstract description 5
- 108090000765 processed proteins & peptides Chemical group 0.000 claims abstract description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 4
- 125000001174 sulfone group Chemical group 0.000 claims abstract description 4
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical group CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 125000003118 aryl group Chemical group 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 125000002252 acyl group Chemical group 0.000 claims description 4
- 239000004094 surface-active agent Substances 0.000 claims description 4
- 125000004001 thioalkyl group Chemical group 0.000 claims description 4
- 239000000080 wetting agent Substances 0.000 claims description 4
- 229910052783 alkali metal Inorganic materials 0.000 claims description 3
- 150000001340 alkali metals Chemical class 0.000 claims description 3
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 125000004414 alkyl thio group Chemical group 0.000 claims description 3
- 125000003368 amide group Chemical group 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 2
- LSMMRJUHLKJNLR-UHFFFAOYSA-N 3-methyl-1,3-benzothiazol-2-one Chemical compound C1=CC=C2SC(=O)N(C)C2=C1 LSMMRJUHLKJNLR-UHFFFAOYSA-N 0.000 claims 1
- 239000006172 buffering agent Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 48
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 39
- 238000003756 stirring Methods 0.000 description 31
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 26
- 230000015572 biosynthetic process Effects 0.000 description 25
- 238000003786 synthesis reaction Methods 0.000 description 25
- 239000011541 reaction mixture Substances 0.000 description 18
- 239000000047 product Substances 0.000 description 17
- 239000012043 crude product Substances 0.000 description 15
- 108090000790 Enzymes Proteins 0.000 description 13
- 102000004190 Enzymes Human genes 0.000 description 13
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 13
- 229940088598 enzyme Drugs 0.000 description 13
- 238000003818 flash chromatography Methods 0.000 description 13
- 239000000741 silica gel Substances 0.000 description 13
- 229910002027 silica gel Inorganic materials 0.000 description 13
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 12
- 239000004202 carbamide Substances 0.000 description 12
- 239000000706 filtrate Substances 0.000 description 12
- 229960003767 alanine Drugs 0.000 description 10
- 238000002844 melting Methods 0.000 description 10
- 230000008018 melting Effects 0.000 description 10
- 125000004432 carbon atom Chemical group C* 0.000 description 9
- 230000003301 hydrolyzing effect Effects 0.000 description 9
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 8
- 238000001514 detection method Methods 0.000 description 7
- 239000012156 elution solvent Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000003480 eluent Substances 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 108091005804 Peptidases Proteins 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 210000000265 leukocyte Anatomy 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 4
- 239000005711 Benzoic acid Substances 0.000 description 4
- 235000010233 benzoic acid Nutrition 0.000 description 4
- 239000002808 molecular sieve Substances 0.000 description 4
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 4
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108090000371 Esterases Proteins 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- ASHGTJPOSUFTGB-UHFFFAOYSA-N 3-methoxyphenol Chemical compound COC1=CC=CC(O)=C1 ASHGTJPOSUFTGB-UHFFFAOYSA-N 0.000 description 2
- NKFRBXPBRPYULV-UHFFFAOYSA-N 4-chloro-3-methoxyphenol Chemical compound COC1=CC(O)=CC=C1Cl NKFRBXPBRPYULV-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108090000604 Hydrolases Proteins 0.000 description 2
- 102000004157 Hydrolases Human genes 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 125000003412 L-alanyl group Chemical group [H]N([H])[C@@](C([H])([H])[H])(C(=O)[*])[H] 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 210000003714 granulocyte Anatomy 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- MLIWQXBKMZNZNF-KUHOPJCQSA-N (2e)-2,6-bis[(4-azidophenyl)methylidene]-4-methylcyclohexan-1-one Chemical compound O=C1\C(=C\C=2C=CC(=CC=2)N=[N+]=[N-])CC(C)CC1=CC1=CC=C(N=[N+]=[N-])C=C1 MLIWQXBKMZNZNF-KUHOPJCQSA-N 0.000 description 1
- LQXKHFZRJYXXFA-QMMMGPOBSA-N (2s)-2-[(4-methylphenyl)sulfonylamino]propanoic acid Chemical compound OC(=O)[C@H](C)NS(=O)(=O)C1=CC=C(C)C=C1 LQXKHFZRJYXXFA-QMMMGPOBSA-N 0.000 description 1
- JYSUYJCLUODSLN-UHFFFAOYSA-N 1,3-benzothiazol-2-ylhydrazine Chemical compound C1=CC=C2SC(NN)=NC2=C1 JYSUYJCLUODSLN-UHFFFAOYSA-N 0.000 description 1
- JTPNRXUCIXHOKM-UHFFFAOYSA-N 1-chloronaphthalene Chemical compound C1=CC=C2C(Cl)=CC=CC2=C1 JTPNRXUCIXHOKM-UHFFFAOYSA-N 0.000 description 1
- UMPSXRYVXUPCOS-UHFFFAOYSA-N 2,3-dichlorophenol Chemical compound OC1=CC=CC(Cl)=C1Cl UMPSXRYVXUPCOS-UHFFFAOYSA-N 0.000 description 1
- UPGSWASWQBLSKZ-UHFFFAOYSA-N 2-hexoxyethanol Chemical compound CCCCCCOCCO UPGSWASWQBLSKZ-UHFFFAOYSA-N 0.000 description 1
- BZSXEZOLBIJVQK-UHFFFAOYSA-N 2-methylsulfonylbenzoic acid Chemical compound CS(=O)(=O)C1=CC=CC=C1C(O)=O BZSXEZOLBIJVQK-UHFFFAOYSA-N 0.000 description 1
- VQZRLBWPEHFGCD-UHFFFAOYSA-N 3-chloro-4-methylphenol Chemical compound CC1=CC=C(O)C=C1Cl VQZRLBWPEHFGCD-UHFFFAOYSA-N 0.000 description 1
- XWNSFEAWWGGSKJ-UHFFFAOYSA-N 4-acetyl-4-methylheptanedinitrile Chemical compound N#CCCC(C)(C(=O)C)CCC#N XWNSFEAWWGGSKJ-UHFFFAOYSA-N 0.000 description 1
- JUIKCULGDIZNDI-UHFFFAOYSA-N 4-chloro-3-nitrophenol Chemical compound OC1=CC=C(Cl)C([N+]([O-])=O)=C1 JUIKCULGDIZNDI-UHFFFAOYSA-N 0.000 description 1
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 1
- BOXYODYSHAHWPN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1.OC(=O)C1=CC=C(O)C=C1 BOXYODYSHAHWPN-UHFFFAOYSA-N 0.000 description 1
- WLHCBQAPPJAULW-UHFFFAOYSA-N 4-methylbenzenethiol Chemical compound CC1=CC=C(S)C=C1 WLHCBQAPPJAULW-UHFFFAOYSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010023424 Kidney infection Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000004153 Potassium bromate Substances 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Chemical group 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- 150000001989 diazonium salts Chemical class 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- NALMPLUMOWIVJC-UHFFFAOYSA-N n,n,4-trimethylbenzeneamine oxide Chemical compound CC1=CC=C([N+](C)(C)[O-])C=C1 NALMPLUMOWIVJC-UHFFFAOYSA-N 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000000405 phenylalanyl group Chemical group 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229940094037 potassium bromate Drugs 0.000 description 1
- 235000019396 potassium bromate Nutrition 0.000 description 1
- LDPWMLSYNVOMKZ-UHFFFAOYSA-M potassium bromite Chemical compound [K+].[O-]Br=O LDPWMLSYNVOMKZ-UHFFFAOYSA-M 0.000 description 1
- VKJKEPKFPUWCAS-UHFFFAOYSA-M potassium chlorate Chemical compound [K+].[O-]Cl(=O)=O VKJKEPKFPUWCAS-UHFFFAOYSA-M 0.000 description 1
- JLKDVMWYMMLWTI-UHFFFAOYSA-M potassium iodate Chemical compound [K+].[O-]I(=O)=O JLKDVMWYMMLWTI-UHFFFAOYSA-M 0.000 description 1
- 239000001230 potassium iodate Substances 0.000 description 1
- 235000006666 potassium iodate Nutrition 0.000 description 1
- 229940093930 potassium iodate Drugs 0.000 description 1
- VXLUZERCXISKBW-UHFFFAOYSA-M potassium;perbromate Chemical compound [K+].[O-]Br(=O)(=O)=O VXLUZERCXISKBW-UHFFFAOYSA-M 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- XUXNAKZDHHEHPC-UHFFFAOYSA-M sodium bromate Chemical compound [Na+].[O-]Br(=O)=O XUXNAKZDHHEHPC-UHFFFAOYSA-M 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000015281 sodium iodate Nutrition 0.000 description 1
- 239000011697 sodium iodate Substances 0.000 description 1
- 229940032753 sodium iodate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- BAZAXWOYCMUHIX-UHFFFAOYSA-M sodium perchlorate Chemical compound [Na+].[O-]Cl(=O)(=O)=O BAZAXWOYCMUHIX-UHFFFAOYSA-M 0.000 description 1
- 229910001488 sodium perchlorate Inorganic materials 0.000 description 1
- NYCVSSWORUBFET-UHFFFAOYSA-M sodium;bromite Chemical compound [Na+].[O-]Br=O NYCVSSWORUBFET-UHFFFAOYSA-M 0.000 description 1
- CLURAKRVQIPBCC-UHFFFAOYSA-M sodium;perbromate Chemical compound [Na+].[O-]Br(=O)(=O)=O CLURAKRVQIPBCC-UHFFFAOYSA-M 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
(発明の利用分野)
本発明は、加水分解酵素用測定器具に関するものである
。詳しく述べると、エステラーゼ、プロテアーゼ等の加
水分解酵素を検出するために用いられる測定器具に関す
るものである。DETAILED DESCRIPTION OF THE INVENTION (Field of Application of the Invention) The present invention relates to a measuring instrument for hydrolytic enzymes. More specifically, the present invention relates to a measuring instrument used to detect hydrolytic enzymes such as esterase and protease.
(従来の技術)
尿中に出現する白血球の量は、腎または尿路感染症の診
断の指針となる。さらに、腹膜透析中の白血球のモニタ
リングは、腹膜炎の早期発見の指針となる。これらの白
血球の検出は、従来、鏡検によって行なわれていたが、
この方法は高価な機器を必要とするだけでなく、長い測
定時間および複雑な測定操作を必要とする等の欠点を有
している。BACKGROUND OF THE INVENTION The amount of white blood cells that appear in the urine guides the diagnosis of kidney or urinary tract infections. Additionally, monitoring leukocytes during peritoneal dialysis can guide early detection of peritonitis. Conventionally, detection of these white blood cells was done by microscopic examination, but
This method not only requires expensive equipment, but also has drawbacks such as long measurement times and complicated measurement operations.
このような問題点を解決するために、白血球中のエステ
ラーゼ、プロテアーゼ等の加水分解酵素を指針とした検
出法が広く行なわれるようになってきた。この方法によ
れば、簡単な操作で、しかも短時間で測定結果が得られ
るという利点がある。In order to solve these problems, detection methods using hydrolytic enzymes such as esterase and protease in leukocytes as guidelines have become widely used. This method has the advantage that measurement results can be obtained with simple operation and in a short time.
また、酵素活性を指針とするために、崩壊した白血球も
検出可能である。すでに、(A)酵素基質としてフェノ
キシアミノ酸エステルを、また顕色剤としてジアゾニウ
ム塩を含有する蛋白質分解酵素の検出法(特公昭61−
45.982号)、(B)インドキシル−アミノ酸エス
テルおよびペプチドエステルを色原体として含有してな
るエステルおよび蛋白質分解酵素の検出法(特公昭59
−3,475号)および(C)5−フェニルピロールエ
ステルを用いた加水分解対象物の検出法(特公昭62−
41,475号)が知られている。In addition, disintegrated white blood cells can also be detected using enzyme activity as a guideline. Already, (A) a method for detecting a proteolytic enzyme containing a phenoxyamino acid ester as an enzyme substrate and a diazonium salt as a color developer (Japanese Patent Publication No. 1983-
45.982), (B) Method for detecting esters and proteolytic enzymes containing indoxyl-amino acid esters and peptide esters as chromogens (Special Publication No. 59
-3,475) and (C) Detection method for hydrolyzed substances using 5-phenylpyrrole ester (Japanese Patent Publication No. 62-
No. 41,475) is known.
しかしながら、これらの方法においても、使用する試薬
が高価である、呈色安定性に欠ける、感度が悪い等の問
題点を有している。However, these methods also have problems such as expensive reagents, lack of color stability, and poor sensitivity.
(発明が解決しようとする課題)
したがって、本発明の目的は、新規な加水分解酵素用測
定器具を提供することにある。本発明の他の目的は、被
検出物である加水分解酵素に対して特異性が高く、かつ
優れた呈色性を示す基質を用いてなり、特別あるいは高
価な装置を必要とせずに簡単な操作で迅速かつ高感度で
測定するための器具を提出することにある。(Problems to be Solved by the Invention) Therefore, an object of the present invention is to provide a novel measuring instrument for hydrolytic enzymes. Another object of the present invention is to use a substrate that has high specificity for the hydrolase to be detected and exhibits excellent coloring properties, and to provide a simple method that does not require any special or expensive equipment. The objective is to provide an instrument for quick and sensitive measurements in operation.
(課題を解決するための手段)
これらの諸口的は、一般式I
(ただし、式中、Aはアミノ酸残基またはアミノ酸残基
2〜5個からなるペプチド基、Bは窒素保護基、Xはハ
ロゲン原子、カルボキシル基、スルホン基またはチオア
ルキル基、R1、R2、R3およびR4は水素原子、ハ
ロゲン原子、アルキル基、アリール基、アルコキシ基、
アシル基、アミド基、ニトロ基およびアルキルチオール
基よりなる群から選ばれたすくなくとも1種のものであ
り、R1とR2およびR3とR4とはそれぞれ縮合芳香
環を形成していてもよい。)で表わされるフェノキシエ
ステル化合物、顕色剤および酸化剤を吸着性担体に保持
したことを特徴とする溶液中の加水分解酵素用測定器具
により達成される。(Means for Solving the Problems) The general formula I (wherein A is an amino acid residue or a peptide group consisting of 2 to 5 amino acid residues, B is a nitrogen protecting group, and X is a Halogen atom, carboxyl group, sulfone group or thioalkyl group, R1, R2, R3 and R4 are hydrogen atoms, halogen atoms, alkyl groups, aryl groups, alkoxy groups,
It is at least one type selected from the group consisting of an acyl group, an amide group, a nitro group, and an alkylthiol group, and R1 and R2 and R3 and R4 may each form a fused aromatic ring. ), a color developer, and an oxidizing agent are retained on an adsorbent carrier.
本発明はまた、該フェノキシエステル化合物100当世
当り顕色剤が100〜200当量および酸化剤が500
〜1,500当量配合されてなる測定器具である。本発
明はさらに、顕色剤が4−アミノアンチピリンまたは3
−メチル−2−ベンゾチアゾリノンである測定器具であ
る。本発明は、酸化剤が一般式■
ZY、、、0、 (II)(ただし、
式中、Zはアルカリ金属、Yはハロゲン原子、mは1〜
3の整数であり、またnは1〜6の整数である)で表わ
される塩である測定器具である。本発明はまた、吸着性
担体が濾紙または布帛である測定器具である。本発明は
さらに、界面活性剤または湿潤剤をさらに配合してなる
測定器具である。本発明は被検出物質である加水分解酵
素の反応に適するpHを有する緩衝剤を配合してなる測
定器具である。本発明はまた、前記測定器具を支持体に
担持してなる測定器具である。The present invention also provides 100 to 200 equivalents of color developer and 500 equivalents of oxidizing agent per 100 equivalents of the phenoxy ester compound.
This is a measuring instrument containing ~1,500 equivalents. The present invention further provides that the color developer is 4-aminoantipyrine or 3-aminoantipyrine.
- Methyl-2-benzothiazolinone. In the present invention, the oxidizing agent has the general formula ■ ZY, , 0, (II) (however,
In the formula, Z is an alkali metal, Y is a halogen atom, and m is 1 to
is an integer of 3, and n is an integer of 1 to 6). The present invention is also a measuring device in which the adsorptive carrier is a filter paper or fabric. The present invention further provides a measuring instrument further comprising a surfactant or a wetting agent. The present invention is a measuring instrument containing a buffer having a pH suitable for the reaction of a hydrolytic enzyme, which is a substance to be detected. The present invention also provides a measuring instrument in which the measuring instrument is supported on a support.
(作用)
本発明によれば、一般式Iで表わされるフェノキシエス
テル化合物は、エステラーゼ、プロテアーゼ等の加水分
解酵素、特に好中球−顆粒球中に存在するものに特異性
が高(、次式に示すごとくエステル結合が分解されて一
般式■で表わされる遊離のフェノールを生じる。(Function) According to the present invention, the phenoxy ester compound represented by the general formula I has high specificity for hydrolytic enzymes such as esterases and proteases, particularly those present in neutrophils and granulocytes (the following formula As shown in Figure 2, the ester bond is decomposed to produce a free phenol represented by the general formula (2).
この遊離フェノールは、顕色剤と縮合されることによっ
て呈色する色原体としての性質を有している。例えば、
顕色剤として4−アミノアンチピリン、3−メチル−2
−ベンゾチアゾリノンヒドラゾン等のカプラーとを、酸
化剤の存在下に縮合させると呈色化合物が生成する。次
式は、4−アミノアンチピリンと縮合した場合の例であ
る。This free phenol has properties as a chromogen that develops color by being condensed with a color developer. for example,
4-aminoantipyrine, 3-methyl-2 as a color developer
- When a coupler such as benzothiazolinone hydrazone is condensed in the presence of an oxidizing agent, a colored compound is produced. The following formula is an example of condensation with 4-aminoantipyrine.
h
本発明の一般式Iで表わされフェノキシエステル化合物
は、エステル結合に対してパラ位にハロゲン原子(好ま
しくは塩素および臭素原子)、カルボキシル基、スルホ
ン基、またはチオアルキル基(アルキル基の炭素原子数
は、好ましくは1〜6)等の脱離基を含むことを特徴と
している。これらの置換基は、酵素分解の後、生成する
遊離のフェノールが前述の顕色剤と縮合する際に、その
反応性を向上させる役割を担っている。その結果、無置
換のフェノールに比較して呈色性能が高まる。h The phenoxy ester compound represented by the general formula I of the present invention has a halogen atom (preferably chlorine and bromine atom), a carboxyl group, a sulfone group, or a thioalkyl group (a carbon atom of the alkyl group) at the para position to the ester bond. The number preferably includes a leaving group such as 1 to 6). These substituents play a role in improving the reactivity of the free phenol generated after enzymatic decomposition when it condenses with the above-mentioned color developer. As a result, the color performance is improved compared to unsubstituted phenol.
さらに、これらの置換基の電子的効果は、基質のエステ
ル結合の分解速度に影響する。例えば、ハロゲンやチオ
アルキル等の電子供与性置換基を導入することによって
エステル結合の安定性が低下し、酵素による切断速度が
高まる。以上のように、該酵素基質のパラ位の置換は、
加水分解酵素の検出において、その感度向−トに高い効
果を示すことが明らかである。Furthermore, the electronic effects of these substituents influence the rate of degradation of the ester bond of the substrate. For example, introducing an electron-donating substituent such as halogen or thioalkyl reduces the stability of the ester bond and increases the rate of enzymatic cleavage. As mentioned above, the substitution at the para position of the enzyme substrate is
It is clear that this method is highly effective in increasing sensitivity in the detection of hydrolytic enzymes.
なお、一般式Iにおいて、Aは、アミノ酸残基またはア
ミノ酸残基2〜5個からなるペプチド基であり、アミノ
酸残基としては、L−アラニル、L−β−アラニル、L
−バリニル、L−イソロイシニル、L−リジニル、L−
フェニルアラニル、L−メチオニル等がある。Bは、窒
素保護基であり、例えばアシル基、オキシカルボニル基
、スルホニル基、ホスホリル基、カルバモイル基、チオ
カルボニル基等がある。R1、R2、R3およびR4は
、水素原子、ハロゲン原子(好ましくは塩素および臭素
原子)、アルキル基(好ましくは炭素原子数1〜10、
より好ましくは1〜4)、アリール基、アルコキシ基(
好ましくは炭素原子数1〜10、より好ましくは1〜4
)、アシル基(好ましくはアルキル部分の炭素原子数が
1〜9、より好ましくは1〜3)、アミド基、ニトロ基
、アルキルチオール基(好ましくはアルキル部分の炭素
原子数が1〜10、より好ましくは1〜4)等があり、
R1とR2およびR3およびR4とはそれぞれ縮合芳香
環を形成していてもよい。In addition, in general formula I, A is an amino acid residue or a peptide group consisting of 2 to 5 amino acid residues, and the amino acid residues include L-alanyl, L-β-alanyl, L-alanyl,
-valinyl, L-isoleucinyl, L-lysinyl, L-
Examples include phenylalanyl and L-methionyl. B is a nitrogen-protecting group, such as an acyl group, an oxycarbonyl group, a sulfonyl group, a phosphoryl group, a carbamoyl group, a thiocarbonyl group, and the like. R1, R2, R3 and R4 are hydrogen atoms, halogen atoms (preferably chlorine and bromine atoms), alkyl groups (preferably 1 to 10 carbon atoms,
More preferably 1 to 4), aryl group, alkoxy group (
Preferably 1 to 10 carbon atoms, more preferably 1 to 4 carbon atoms
), acyl group (preferably the alkyl moiety has 1 to 9 carbon atoms, more preferably 1 to 3 carbon atoms), amide group, nitro group, alkylthiol group (preferably the alkyl moiety has 1 to 10 carbon atoms, more Preferably, there are 1 to 4), etc.
R1 and R2 and R3 and R4 may each form a fused aromatic ring.
本発明で使用される一般式Iで表わされるフェノキシエ
ステル化合物の一例を具体的に示すと、例えば、つぎの
とおりである。Specific examples of the phenoxy ester compound represented by the general formula I used in the present invention are as follows.
(1)1−(N−p−トルエンスルホニル−L−アラニ
ルオキシ)−4−クロロベンゼン、
(2) 1−(N−p−)ルエンスルホニルーL−アラ
ニルオキシ)−2,4−ジクロロベンゼン、
(3) 1−(N−p−トルエンスルホニル−L−アラ
ニルオキシ) −3、4−ジクロロベンゼン、
(4)1−(N−p−トルエンスルホニル−し−アラニ
ルオキシ)−3−メトキシ−4−クロロベンゼン、(5
)4−(N−p−トルエンスルホニル−し−アラニルオ
キシ)−2−クロロトルエン、
(6)1−(N−p−)ルエンスルホニル−L−アラニ
ルオキシ)−3−アセチル−4−クロロベンゼン、(7
)l−<N−p−)ルエンスルホニルーL−アラニルオ
キシ)−3−ニトロ−4−クロロベンゼン、(8)l−
(N−p−)ルエンスルホニルーL−アラニルオキシ)
−4−クロロナフタレン、
(9)l−(N−p−トルエンスルホニル−L−アラニ
ルオキシ)−4−ブロモベンゼン、
(10)4−(N−p−トルエンスルホニル−L−アラ
ニルオキシ〉安息香酸、
(11)2−メトキシ−4−(N−p−トルエンスルホ
ニル−し−アラニルオキシ)安息香酸、
(12)1−(N−p−トルエンスルホニル−L−アラ
ニルオキシ)−4−メチルチオベンゼン等。(1) 1-(N-p-toluenesulfonyl-L-alanyloxy)-4-chlorobenzene, (2) 1-(N-p-)toluenesulfonyl-L-alanyloxy)-2,4-dichlorobenzene, (3 ) 1-(N-p-toluenesulfonyl-L-alanyloxy)-3,4-dichlorobenzene, (4) 1-(N-p-toluenesulfonyl-l-alanyloxy)-3-methoxy-4-chlorobenzene, ( 5
) 4-(N-p-toluenesulfonyl-l-alanyloxy)-2-chlorotoluene, (6) 1-(N-p-)toluenesulfonyl-L-alanyloxy)-3-acetyl-4-chlorobenzene, (7
) l-<N-p-) luenesulfonyl-L-alanyloxy)-3-nitro-4-chlorobenzene, (8) l-
(N-p-)luenesulfonyl-L-alanyloxy)
-4-chloronaphthalene, (9) l-(N-p-toluenesulfonyl-L-alanyloxy)-4-bromobenzene, (10) 4-(N-p-toluenesulfonyl-L-alanyloxy)benzoic acid, ( 11) 2-methoxy-4-(N-p-toluenesulfonyl-l-alanyloxy)benzoic acid, (12) 1-(N-p-toluenesulfonyl-L-alanyloxy)-4-methylthiobenzene, and the like.
前記フェノキシエステル化合物が検出目的の酵素によっ
て加水分解を受け、生成する遊離のフェノール化合物が
顕色剤と縮合する際には、酸化剤を必要とする。An oxidizing agent is required when the phenoxy ester compound is hydrolyzed by an enzyme for the purpose of detection and the generated free phenol compound is condensed with a color developer.
本発明で使用される酸化剤は一般式■
ZYIl、 0n(II)
(ただし、式中、Zはアルカリ金属、好ましくはナトリ
ウムまたはカリウム、より好ましくはナトリウム、Yは
ハロゲン原子、mは1〜3の整数であり、またnは1〜
6の整数である)で表わされる塩である。−例を挙げる
と、例えば、ヨウ素酸ナトリウム、過ヨウ素酸ナトリウ
ム、臭素酸ナトリウム、過臭素酸ナトリウム、亜臭素酸
ナトリウム、塩素酸ナトリウム、過塩素酸ナトリウム、
ヨウ素酸カリウム、過ヨウ素酸カリウム、臭素酸カリウ
ム、過臭素酸カリウム、亜臭素酸カリウム、塩素酸カリ
ウム等がある。The oxidizing agent used in the present invention has the general formula: ZYIl, On(II) (wherein, Z is an alkali metal, preferably sodium or potassium, more preferably sodium, Y is a halogen atom, and m is 1 to 3 n is an integer from 1 to
is an integer of 6). - for example, sodium iodate, sodium periodate, sodium bromate, sodium perbromate, sodium bromite, sodium chlorate, sodium perchlorate,
Potassium iodate, potassium periodate, potassium bromate, potassium perbromate, potassium bromite, potassium chlorate, etc.
本発明による試験器具において、前記フェノキシエステ
ル化合物100当量に対する顕色剤の配合量は100〜
200当量、好ましくは100〜150当量であり、ま
た酸化剤の配合量は500〜1,500当量である。In the test device according to the present invention, the amount of the color developer to be blended is 100 to 100 equivalents of the phenoxyester compound.
The amount is 200 equivalents, preferably 100 to 150 equivalents, and the amount of the oxidizing agent is 500 to 1,500 equivalents.
該フェノキシエステル化合物、顕色剤、酸化剤および必
要によりその他の反応助剤の溶液を、担体に含浸させた
のち、乾燥させることによって測定器具が得られる。A measuring instrument is obtained by impregnating a carrier with a solution of the phenoxy ester compound, a color developer, an oxidizing agent, and other reaction aids if necessary, and then drying the carrier.
担体としては、濾紙、布帛(例えば織布、編布、不織布
等)等がある。Examples of carriers include filter paper, fabrics (eg, woven fabrics, knitted fabrics, nonwoven fabrics, etc.).
また、前記溶液には、必要により界面活性剤または湿潤
剤が配向される。界面活性剤ないし湿潤剤としては、ト
リトンX−100、ラウリル硫酸ナトリウム、スパン、
トゥイーン、ポリエチレングリコール、高級アルコール
類、エーテルアルコール類等が挙げられ、好ましくは炭
素原子数8〜12の直鎖アルコール、炭素原子数8〜1
5のエーテル結合を含む直鎖のアルコールが用いられる
。Further, a surfactant or a wetting agent is added to the solution as necessary. As surfactants or wetting agents, Triton X-100, sodium lauryl sulfate, Span,
Examples include Tween, polyethylene glycol, higher alcohols, ether alcohols, etc., preferably linear alcohols having 8 to 12 carbon atoms, and 8 to 1 carbon atoms.
A straight chain alcohol containing 5 ether bonds is used.
また、前記溶液には、検出目的の加水分解酵素の反応に
適するpHを有する緩衝剤が必要により配合される。こ
のような緩衝剤としては、例えばリン酸緩衝液、ホウ酸
緩衝液、トリス緩衝液、クエン酸緩衝液等がある。In addition, a buffer having a pH suitable for the reaction of the hydrolase for detection purposes is added to the solution, if necessary. Examples of such buffers include phosphate buffer, borate buffer, Tris buffer, citrate buffer, and the like.
前記試験器具は、支持体に担持させることにより把手の
ついた試験器具が得られる。このよう支持体としては、
プラスチックス、金属、木材等の板状物があり、接着剤
等を介して固着される。By supporting the test device on a support, a test device with a handle can be obtained. In this way, as a support,
There are plate-like objects such as plastics, metals, and wood, which are fixed using adhesives.
被測定試料は、前記測定器具の上に滴下するか、あるい
は該測定器具を被測定試料液中に浸漬したのち、色調変
化を目視ないしは分光光度計にて反射吸光度をmす定す
ることにより読み取る。The sample to be measured is dropped onto the measuring instrument, or after the measuring instrument is immersed in the sample liquid to be measured, the color tone change is visually observed or the reflected absorbance is measured using a spectrophotometer. .
(実施例)
つぎに、実施例を挙げて本発明をさらに詳細に説明する
。(Example) Next, the present invention will be described in further detail by giving examples.
合成例1
l−(N−p−トルエンスルホニル−L−アラニルオキ
シ)−4−クロロベンゼンの合成
p−クロロフェノール1.0 g (7,78mm o
1 )、N−p−トルエンスルホニル−し−アラニン
2.19g (9,Osmol) 、4−N、N−ジメ
チルアミノピリジン122 mg(1、Ommolをジ
クロロメタン25m1に溶解し、0℃で撹拌しながらジ
シクロへキシルカルボジイミド1.86゜(9,Omm
ol)を加えた。0℃で1時間撹拌後、室温にてさらに
10時間撹拌を続ける。反応混合物を吸引濾過して生成
した尿素を除去した後、濾液を減圧濃縮し粗生成物を得
た。これを、酢酸エチル3 / n−ヘキサン7を溶出
溶媒とするシリカゲルフラッシュクロマトグラフに供し
、1−(N−p)ルエンスルホニルーL−アラニルオキ
シ)−4−クロロベンゼン2.66g (収率96.7
%)を得た。このものは油状物であった。Synthesis Example 1 Synthesis of l-(N-p-toluenesulfonyl-L-alanyloxy)-4-chlorobenzene p-chlorophenol 1.0 g (7,78 mm o
1), 2.19 g of N-p-toluenesulfonyl-thi-alanine (9, Osmol), 122 mg of 4-N,N-dimethylaminopyridine (1, Ommol) was dissolved in 25 ml of dichloromethane, and the mixture was stirred at 0°C. Dicyclohexylcarbodiimide 1.86° (9, Omm
ol) was added. After stirring for 1 hour at 0°C, stirring is continued for an additional 10 hours at room temperature. After the reaction mixture was suction filtered to remove the generated urea, the filtrate was concentrated under reduced pressure to obtain a crude product. This was subjected to silica gel flash chromatography using ethyl acetate 3/n-hexane 7 as an elution solvent to obtain 2.66 g of 1-(N-p)luenesulfonyl-L-alanyloxy)-4-chlorobenzene (yield 96.7).
%) was obtained. This stuff was oily.
合成例2
l−(N−p−トルエンスルホニル−し−アラニルオキ
シ)−2,4−ジクロロベンゼンの合成■、3−ジクロ
ロフェノール1.0 g (6,13mmol)、N−
p−)ルエンスルホニルーL−アラニン1.79g (
7,46mmol)、4−N、N−ジメチルアミノピリ
ジン122 mg(1、Ommol)を、ジクロロメタ
ン25m1に溶解し、0℃で撹拌しながらD CC1,
52g (7,36111[1101)を加える。Synthesis Example 2 Synthesis of l-(N-p-toluenesulfonyl-shi-alanyloxy)-2,4-dichlorobenzene ■, 3-dichlorophenol 1.0 g (6.13 mmol), N-
p-) Luenesulfonyl-L-alanine 1.79g (
7,46 mmol), 4-N,N-dimethylaminopyridine (122 mg (1,0 mmol)) was dissolved in 25 ml of dichloromethane and stirred at 0°C.
Add 52g (7,36111[1101).
0℃で1時間攪拌後、室温にてさらに10時間撹拌を続
ける。反応混合物を吸引濾過して生成した尿素を除去し
た後、濾液を減圧濃縮し粗生成物を寿だ。これを、酢酸
エチル3/n−ヘキサン7を溶出溶媒とするシリカゲル
フラッシュクロマトグラフに供し、目的物2.22g
(収率93.2%)を得た。このものの融点は156℃
であった。After stirring at 0°C for 1 hour, stirring is continued at room temperature for an additional 10 hours. After the reaction mixture was suction-filtered to remove the generated urea, the filtrate was concentrated under reduced pressure to obtain a crude product. This was subjected to silica gel flash chromatography using ethyl acetate 3/n-hexane 7 as an elution solvent, and 2.22 g of the target product was obtained.
(yield 93.2%). The melting point of this substance is 156℃
Met.
合成例3
l−(N−p−トルエンスルホニル−し−アラニルオキ
シ)−3,4−ジクロロベンゼンの合成1.2−ジクロ
ロフェノールL、Og (6,13gmol)、N−p
−トルエンスルホニル−L−アラニン1.79g (7
,46mmol)、4−N、N−ジメチルアミノピリジ
ン122 mg(1,Ommol)を、ジクロロメタン
251に溶解し、0℃で撹拌しながらD CC1,52
g (7,36mmol)を加える。Synthesis Example 3 Synthesis of l-(N-p-toluenesulfonyl-shi-alanyloxy)-3,4-dichlorobenzene 1.2-dichlorophenol L, Og (6,13 gmol), N-p
-Toluenesulfonyl-L-alanine 1.79g (7
, 46 mmol), 122 mg (1,0 mmol) of 4-N,N-dimethylaminopyridine was dissolved in dichloromethane 251, and D CC1,52 was added with stirring at 0°C.
g (7.36 mmol) is added.
0℃で1時間攪拌後、室温にてさらに10時間撹拌を続
ける。反応混合物を吸引濾過して生成した尿素を除去し
た後、濾液を減圧濃縮し粗生成物を得た。これを、酢酸
エチル3/n−ヘキサン7を溶出溶媒とするシリカゲル
フラッシュクロマトグラフに供し、目的物2.18g
(収率91.7%)を得た。このものの融点は144℃
であった。After stirring at 0°C for 1 hour, stirring is continued at room temperature for an additional 10 hours. After the reaction mixture was suction filtered to remove the generated urea, the filtrate was concentrated under reduced pressure to obtain a crude product. This was subjected to silica gel flash chromatography using ethyl acetate 3/n-hexane 7 as an eluent, yielding 2.18 g of the target product.
(yield 91.7%). The melting point of this substance is 144℃
Met.
合成例4
l−(N−p−トルエンスルホニル−し−アラニルオキ
シ)−3−メトキシ−4−クロロベンゼンの合成3−メ
トキシフェノール3.0 g (24,17mmol)
をジクロロメタン20m1に溶解し0℃で撹拌しながら
塩化スルフリル2.0 ml (24,2mmol)を
ゆっ(り加える。Synthesis Example 4 Synthesis of l-(N-p-toluenesulfonyl-shi-alanyloxy)-3-methoxy-4-chlorobenzene 3-methoxyphenol 3.0 g (24.17 mmol)
Dissolve in 20 ml of dichloromethane and slowly add 2.0 ml (24.2 mmol) of sulfuryl chloride while stirring at 0°C.
そのまま、1.5時間反応後、氷水に投入し、反応混合
物を酢酸エチルで抽出する。有機層を炭酸水素ナトリウ
ム水溶液、塩化ナトリウム水溶液にて洗浄後、減圧濃縮
し粗生成物を得た。これを、酢酸エチル2/n−へキサ
ン8を溶出溶媒とするシリカゲルフラッシュクロマトグ
ラフに供し、3−メトキシ−4−クロロフェノール2.
82g (収率73.6%)を得た。After reacting for 1.5 hours, the reaction mixture was poured into ice water, and the reaction mixture was extracted with ethyl acetate. The organic layer was washed with an aqueous sodium hydrogen carbonate solution and an aqueous sodium chloride solution, and then concentrated under reduced pressure to obtain a crude product. This was subjected to silica gel flash chromatography using ethyl acetate 2/n-hexane 8 as an eluent, and 3-methoxy-4-chlorophenol 2.
82 g (yield 73.6%) was obtained.
1−(N−p−)ルエンスルホニルーL−アラニルオキ
シ)−3−メトキシ−4−クロロベンゼン3−メトキシ
−p−クロロフェノール2.8 g(16,4mmol
)、N−p−トルエンスルホニル−L−アラニン4.3
7g(18,Ommol) 、4−N、N−ジメチル
アミノピリジン183 mg(1,5mmol)をジク
ロロメタン30m1に溶解し、0℃で撹拌しなからD
CC3,71g (18,Ommol)を加える。0℃
で1時間撹拌後、室温にてさらに10時間撹拌を続ける
。反応混合物を吸引濾過して生成した尿素を除去した後
、濾液を減圧濃縮し粗生成物を得た。これを、酢酸エチ
ル2/n−ヘキサン8を溶出溶媒とするシリカゲルフラ
ッシュクロマトグラフに供し、1−N−1)−)ルエン
スルホニルーL−アラニンオキシ)−3−メトキシ−4
−クロロベンゼン2.02g (収率83,4%)を得
た。このものの融点は152°Cであった。1-(N-p-)luenesulfonyl-L-alanyloxy)-3-methoxy-4-chlorobenzene 3-methoxy-p-chlorophenol 2.8 g (16.4 mmol
), N-p-toluenesulfonyl-L-alanine 4.3
7 g (18, Ommol), 183 mg (1.5 mmol) of 4-N,N-dimethylaminopyridine were dissolved in 30 ml of dichloromethane, and stirred at 0°C.
Add 71 g (18, Ommol) of CC3. 0℃
After stirring for 1 hour at room temperature, stirring was continued for an additional 10 hours. After the reaction mixture was suction filtered to remove the generated urea, the filtrate was concentrated under reduced pressure to obtain a crude product. This was subjected to silica gel flash chromatography using ethyl acetate 2/n-hexane 8 as an eluent.
-2.02 g of chlorobenzene (yield 83.4%) was obtained. The melting point of this product was 152°C.
合成例5
4−(N−p−トルエンスルホニル−し−アラニルオキ
シ)−2−クロロトルエンの合成
2−クロロ−4−ヒドロキシトルエン1.0 g(7,
01a+mol)、N−p−トルエンスルホニル−し−
アラニン2.05g (8,42mmol)、4−N、
N−ジメチルアミノピリジン122 mg(1,Omm
ol)を、ジクロロメタン25m1に溶解し、0℃で撹
拌しながらD CC1,52g (7,36mmol)
を加えた。0℃で1時間撹拌後、室温にてさらに10時
間撹拌を続ける。反応混合物を吸引濾過して生成した尿
素を除去した後、濾液を減圧濃縮し粗生成物を得た。こ
れを、酢酸エチル3 / n−ヘキサン7を溶出溶媒と
するシリカゲルフラッシュクロマトグラフに供し、目的
物2.46g (収率95.4%)を得た。このものの
融点は168℃であった。Synthesis Example 5 Synthesis of 4-(N-p-toluenesulfonyl-shi-alanyloxy)-2-chlorotoluene 2-chloro-4-hydroxytoluene 1.0 g (7,
01a+mol), N-p-toluenesulfonyl-
Alanine 2.05g (8.42mmol), 4-N,
N-dimethylaminopyridine 122 mg (1, Omm
ol) in 25 ml of dichloromethane, and while stirring at 0°C, 1.52 g (7.36 mmol) of DCC was added.
added. After stirring for 1 hour at 0°C, stirring is continued for an additional 10 hours at room temperature. After the reaction mixture was suction filtered to remove the generated urea, the filtrate was concentrated under reduced pressure to obtain a crude product. This was subjected to silica gel flash chromatography using ethyl acetate 3/n-hexane 7 as an elution solvent to obtain 2.46 g (yield 95.4%) of the desired product. The melting point of this product was 168°C.
合成例6
l−(N−p−トルエンスルホニル−し−アラニルオキ
シ)−3−アセチル−4−クロロベンゼンの合成2−ク
ロロ−5−ヒドロキシアセトフェノン1.0 g(5,
86mmol)、N−p−トルエンスルホニル−し−ア
ラニン1.71g (7,04111mol)、4−N
、N−ジメチルアミノピリジン122 mg(1,0m
mol)を、ジクロロメタン25m1に溶解し、0℃で
撹拌しながらD CC1,45g (7,04mmol
)を加えた。0℃で1時間撹拌後、室温にてさらに10
時間撹拌を続ける。反応混合物を吸引濾過して生成した
尿素を除去した後、濾液を減圧濃縮し粗生成物を得た。Synthesis Example 6 Synthesis of l-(N-p-toluenesulfonyl-shi-alanyloxy)-3-acetyl-4-chlorobenzene 2-chloro-5-hydroxyacetophenone 1.0 g (5,
86 mmol), N-p-toluenesulfonyl-di-alanine 1.71 g (7,04111 mol), 4-N
, N-dimethylaminopyridine 122 mg (1,0 m
mol) was dissolved in 25 ml of dichloromethane, and while stirring at 0°C, 1.45 g of DCC (7.04 mmol
) was added. After stirring at 0°C for 1 hour, the mixture was stirred for an additional 10 minutes at room temperature.
Continue stirring for an hour. After the reaction mixture was suction filtered to remove the generated urea, the filtrate was concentrated under reduced pressure to obtain a crude product.
これを、酢酸エチル3 / n−ヘキサン7を溶出溶媒
とするシリカゲルフラッシュクロマトグラフに供し、目
的物2.07g (収率89.1%)を得た。このもの
の融点は193℃であった。This was subjected to silica gel flash chromatography using ethyl acetate 3/n-hexane 7 as an elution solvent to obtain 2.07 g (yield 89.1%) of the target product. The melting point of this product was 193°C.
合成例7
l−(N−p−トルエンスルホニル−L−アラニルオキ
シ)−3−二トロー4−クロロベンゼンの合成3−ニト
ロ−4−クロロフェノール1.0 g (5,76mm
。Synthesis Example 7 Synthesis of l-(N-p-toluenesulfonyl-L-alanyloxy)-3-nitro-4-chlorobenzene 1.0 g (5,76 mm) of 3-nitro-4-chlorophenol
.
1)、N−p−トルエンスルホニル−L−アラニン1.
68g(6,91mmol)、4−N、N−ジメチルア
ミノピリジン122mg(1,0mmol)を、ジクロ
ロメタン25m1に溶解し、0℃で撹拌しながらD C
C1,43g (6,91mmol)を加えた。0°C
で1時間撹拌後、室温にてさらに20時間撹拌を続ける
。反応混合物を吸引濾過して生成した尿素を除去した後
、濾液を減圧濃縮し粗生成物を得た。これを、酢酸エチ
ル3/n−ヘキサン7を溶出溶媒とするシリカゲルフラ
ッシュクロマトグラフに供し、目的物2.11g (収
率91.8%)を得た。このものの融点は206℃であ
った。1), N-p-toluenesulfonyl-L-alanine 1.
68 g (6.91 mmol) and 122 mg (1.0 mmol) of 4-N,N-dimethylaminopyridine were dissolved in 25 ml of dichloromethane and stirred at 0°C with DC
C1.43g (6.91 mmol) was added. 0°C
After stirring for 1 hour at room temperature, stirring is continued for an additional 20 hours. After the reaction mixture was suction filtered to remove the generated urea, the filtrate was concentrated under reduced pressure to obtain a crude product. This was subjected to silica gel flash chromatography using ethyl acetate 3/n-hexane 7 as an elution solvent to obtain 2.11 g (yield 91.8%) of the desired product. The melting point of this product was 206°C.
合成例8
l−(N−p−トルエンスルホニル−し−アラニンオキ
シ)−4−クロロナフタレン
4−クロロナフタレン1.0 g (6,15mmol
) 、N−p−トルエンスルホニル−し−アラニン1.
61g (6,60mmol)、4−N、N−ジメチル
アミノピリジン122 mg(1,0mmol)をジク
ロロメタン30m1に溶解し、0℃で撹拌しながらD
CC1,36g (6,60mmol)を加える。Synthesis Example 8 l-(N-p-toluenesulfonyl-shi-alanineoxy)-4-chloronaphthalene 4-chloronaphthalene 1.0 g (6.15 mmol
), N-p-toluenesulfonyl-cycloalanine 1.
61 g (6.60 mmol) and 122 mg (1.0 mmol) of 4-N,N-dimethylaminopyridine were dissolved in 30 ml of dichloromethane and stirred at 0°C.
Add 1.36 g (6.60 mmol) of CC.
0℃で1時間撹拌後、室温にてさらに14時間撹拌を続
ける。反応混合物を吸引濾過して生成した尿素を除去し
た後、濾液を減圧濃縮し粗生成物を得た。これを、酢酸
エチル3/n−ヘキサン7を溶出溶媒とするシリカゲル
フラッシュクロマトグラフに供し、1−(N−p−トル
エンスルホニル−し−アラニンオキシ)−4−クロロナ
フタレン2.16g (収率90.6%)を得た。この
ものの融点は181℃であった。After stirring for 1 hour at 0°C, stirring is continued for an additional 14 hours at room temperature. After the reaction mixture was suction filtered to remove the generated urea, the filtrate was concentrated under reduced pressure to obtain a crude product. This was subjected to silica gel flash chromatography using ethyl acetate 3/n-hexane 7 as an elution solvent, and 2.16 g of 1-(N-p-toluenesulfonyl-thi-alanineoxy)-4-chloronaphthalene (yield 90 .6%) was obtained. The melting point of this product was 181°C.
合成例9
l−(N−p−)ルエンスルホニルーL−アラニルオキ
シ)−4−ブロモベンゼンの合成
4−ブロモフェノール1.0 g (5,78mmol
) 、N−p−トルエンスルホニル−L−アラニン1.
89g (8,94III層of)、4−N、N−ジメ
チルアミノピリジン122 mg(1,0麿mol)を
ジクロロメタン25m1に溶解し、0℃で撹拌しながら
D CC1,43g’(6,94+nmol)を加えた
。Synthesis Example 9 Synthesis of l-(N-p-)luenesulfonyl-L-alanyloxy)-4-bromobenzene 4-bromophenol 1.0 g (5,78 mmol
), N-p-toluenesulfonyl-L-alanine 1.
Dissolve 89 g (8,94 III layer of), 122 mg (1,0 mol) of 4-N,N-dimethylaminopyridine in 25 ml of dichloromethane, and add 1,43 g' (6,94+ nmol) of DCC while stirring at 0°C. added.
0℃で1時間撹拌後、室温にてさらに10時間撹拌を続
ける。反応混合物を吸引濾過して生成した尿素を除去し
た後、濾液を減圧濃縮し粗生成物を得た。これを、酢酸
エチル3 / n−ヘキサン7を溶出溶媒とするシリカ
ゲルフラッシュクロマトグラフに供し、目的物2.20
g (収率95.4%)を得た。After stirring for 1 hour at 0°C, stirring is continued for an additional 10 hours at room temperature. After the reaction mixture was suction filtered to remove the generated urea, the filtrate was concentrated under reduced pressure to obtain a crude product. This was subjected to silica gel flash chromatography using ethyl acetate 3/n-hexane 7 as an elution solvent, and the target product 2.20
g (yield 95.4%) was obtained.
このものは油状物であった。This stuff was oily.
合成例10
4−ヒドロキシ安息香酸オキサゾリン保護体の合成
4−ヒドロキシ安息香酸2.Og (14,5mll1
ol)、2−アミノ−2−メチル−1−プロパツール5
.0 g (56,lll1m。Synthesis Example 10 Synthesis of oxazoline protected form of 4-hydroxybenzoic acid 4-hydroxybenzoic acid 2. Og (14,5ml1
ol), 2-amino-2-methyl-1-propatool 5
.. 0 g (56,lll1m.
1)を、トルエン201と1.4−ジオキサン2011
の混合溶媒中で6時間加熱還流した。反応系に生成する
水を吸着する為のモレキュラシーブを適量添加して反応
を行った。反応混合物は濾過によってモレキュラシーブ
を除去した後、減圧乾固を行い、粗生成物2.3gを得
た(収率83.0%)。1), toluene 201 and 1,4-dioxane 2011
The mixture was heated under reflux for 6 hours in a mixed solvent of The reaction was carried out by adding an appropriate amount of molecular sieve to the reaction system to adsorb water generated. After removing the molecular sieve from the reaction mixture by filtration, it was dried under reduced pressure to obtain 2.3 g of a crude product (yield: 83.0%).
4−(N−p−トルエンスルホニル−L−アラニルオキ
シ)安息香酸オキサゾリン保護体の合成4−ヒドロキシ
安息香酸オキサゾリン保護体1.。Synthesis of 4-(N-p-toluenesulfonyl-L-alanyloxy)benzoic acid oxazoline protected form 4-hydroxybenzoic acid oxazoline protected form 1. .
r (5,23mmol) 、N−p−トルエンスルホ
ニル−し−アラニン1.53g (6,60++++a
ol)、4−N、N−ジメチルアミノピリジン122
mg(1,0膳■of)をジクロロメタン20m1に溶
解し、0℃で撹拌しながらD CC1,29g (6,
28mmol)を加えた。0℃で1時間撹拌後、室温に
てさらに15時間撹拌を続ける。反応混合物を吸引濾過
して生成した尿素を除去した後、濾液を減圧濃縮し粗生
成物を得た。これを、2N塩酸3.0mlとエタノール
5.0mlの混合物に溶解し、室温で15時間反応させ
た。反応混合物に水を添加して酢酸エチルで抽出し、減
圧濃縮後、酢酸エチル4/n−ヘキサン6を溶出溶媒と
するシリカゲルフラッシュクロマトグラフに供し、目的
物1.23g (収率64.8%)を得た。このものの
融点は232℃であった。r (5,23 mmol), N-p-toluenesulfonyl-thi-alanine 1.53 g (6,60++++a
ol), 4-N,N-dimethylaminopyridine 122
mg (1,0 servings of) was dissolved in 20 ml of dichloromethane, and while stirring at 0°C, 1,29 g of DCC (6,
28 mmol) was added. After stirring at 0° C. for 1 hour, stirring is continued for an additional 15 hours at room temperature. After the reaction mixture was suction filtered to remove the generated urea, the filtrate was concentrated under reduced pressure to obtain a crude product. This was dissolved in a mixture of 3.0 ml of 2N hydrochloric acid and 5.0 ml of ethanol, and reacted at room temperature for 15 hours. Water was added to the reaction mixture, extracted with ethyl acetate, concentrated under reduced pressure, and subjected to silica gel flash chromatography using ethyl acetate 4/n-hexane 6 as an eluent to obtain 1.23 g of the desired product (yield 64.8%). ) was obtained. The melting point of this product was 232°C.
合成例11
2−メトキシ−4−ヒドロキシ安息香酸オキサゾリン保
護体の合成
2−メトキシ−4−ヒドロキシ安息香酸2.Og(11
゜9mmol)、2−アミノ−2−メチル−1−プロパ
ツール4゜24g (47,6mmol)を、トルエン
20m lと1.4−ジオキサン20m1の混合溶媒中
で6時間加熱還流した。反応系に生成する水を吸着する
為のモレキュラシーブを適量添加して反応を行った。反
応混合物は濾過によってモレキュラシーブを除去した後
、減圧乾固を行い、粗生成物2.08gを得た(収率7
9.0%)。Synthesis Example 11 Synthesis of oxazoline protected form of 2-methoxy-4-hydroxybenzoic acid 2-methoxy-4-hydroxybenzoic acid 2. Og(11
4.24 g (47.6 mmol) of 2-amino-2-methyl-1-propatol was heated under reflux for 6 hours in a mixed solvent of 20 ml of toluene and 20 ml of 1,4-dioxane. The reaction was carried out by adding an appropriate amount of molecular sieve to the reaction system to adsorb water generated. After removing the molecular sieve from the reaction mixture by filtration, it was dried under reduced pressure to obtain 2.08 g of a crude product (yield 7).
9.0%).
2−メトキシ−4−(N−p−トルエンスルホニル−し
−アラニルオキシ)安息香酸オキサゾリン保護体の合成
2−メトキシ−4−ヒドロキシ安息香酸オキサゾリン保
護体1.0 g (4,52mmol) 、N−p−)
ルエンスルホニルーL−アラニンlJ2g (5,43
mmol)、4−N、N−ジメチルアミノピリジン12
2 mg(1,0mmol)をジクロロメタン20m1
に溶解し、0℃で撹拌しながらDCC1,12g (5
,43mmol)を加えた。0℃で1時間撹拌後、室温
にてさらに15時間撹拌を続ける。反応混合物を吸引濾
過して生成した尿素を除去した後、濾液を減圧濃縮し粗
生成物を得た。これを、2N塩酸3.0mlとエタノー
ル5.0a+1の混合物に溶解し、室温で15時間反応
させた。反応混合物に水を添加して酢酸エチルで抽出し
、減圧濃縮後、酢酸エチル4 / n−ヘキサン6を溶
出溶媒とするシリカゲルフラッシュクロマトグラフに供
し、目的物1.20g (収率67.2%)を得た。こ
のものの融点は197℃であった。Synthesis of 2-methoxy-4-(N-p-toluenesulfonyl-s-alanyloxy)benzoic acid oxazoline protected form 2-methoxy-4-hydroxybenzoic acid oxazoline protected form 1.0 g (4,52 mmol), N-p −)
Luenesulfonyl-L-alanine lJ2g (5,43
mmol), 4-N,N-dimethylaminopyridine 12
2 mg (1.0 mmol) in 20 ml of dichloromethane
1.12 g of DCC (5
, 43 mmol) was added. After stirring at 0° C. for 1 hour, stirring is continued for an additional 15 hours at room temperature. After the reaction mixture was suction filtered to remove the generated urea, the filtrate was concentrated under reduced pressure to obtain a crude product. This was dissolved in a mixture of 3.0 ml of 2N hydrochloric acid and 5.0 a+1 ethanol, and reacted at room temperature for 15 hours. Water was added to the reaction mixture, extracted with ethyl acetate, concentrated under reduced pressure, and subjected to silica gel flash chromatography using ethyl acetate 4/n-hexane 6 as an eluent to obtain 1.20 g of the desired product (yield 67.2%). ) was obtained. The melting point of this product was 197°C.
合成例12
1−(N−p−)ルエンスルホニルーL−アラニルオキ
シ)−4−メチルチオベンゼンの合成
4−メチルチオフェノール1.0 g (7,13mm
ol)、N−p−)ルエンスルホニルーL−アラニン2
.08g (8,58mmol)、4−N、N−ジメチ
ルアミノピリジン122 +ng(1,0mmol)を
ジクロロメタン25m1に溶解し、0℃で撹拌しながら
D CC1,76K (8−56mmol)を加えた。Synthesis Example 12 Synthesis of 1-(N-p-)luenesulfonyl-L-alanyloxy)-4-methylthiobenzene 4-methylthiophenol 1.0 g (7.13 mm
ol), N-p-) luenesulfonyl-L-alanine 2
.. 08 g (8,58 mmol), 122 + ng (1,0 mmol) of 4-N,N-dimethylaminopyridine were dissolved in 25 ml of dichloromethane, and DCC1,76K (8-56 mmol) was added with stirring at 0°C.
0℃で1時間撹拌後、室温にてさらに10時間撹拌を続
ける。反応混合物を吸引濾過して生成した尿素を除去し
た後、濾液を減圧濃縮し粗生成物を得た。これを、酢酸
エチル3 / n−ヘキサン7を溶出溶媒とするシリカ
ゲルフラッシュクロマトグラフに供し、目的物2.31
g (収率88.6%)を得た。After stirring for 1 hour at 0°C, stirring is continued for an additional 10 hours at room temperature. After the reaction mixture was suction filtered to remove the generated urea, the filtrate was concentrated under reduced pressure to obtain a crude product. This was subjected to silica gel flash chromatography using ethyl acetate 3/n-hexane 7 as an eluent, and the target product 2.31
g (yield 88.6%) was obtained.
このものの融点は169℃であった。The melting point of this product was 169°C.
実施例1〜12
濾紙(アトバンチツクNo、 1650)を、100m
M過ヨウ素酸ナトリウム、200mMボラツクスー塩酸
緩衝液(pH=8.0)を含有する水溶液に含浸し、6
0℃で50分通風乾燥した。さらにこの濾紙を、10m
Mの第1表に示すフェノキシエステル化合物、10mM
4−アミノアンチピリンおよび2%エチレングリコール
モノヘキシルエーテルを含有するクロロホルム溶液に含
浸し、40℃で20分通風乾燥した。これを5%5mm
角に切断し、200個/μm顆粒球画分PBS懸濁液を
滴下し、1.5分後の呈色変化を試験紙表面の500n
mの反射吸光度を測定することにより観察した。測定は
大塚電子株式会社製のMCPD−200を用いて測定し
た。Examples 1 to 12 Filter paper (Atobanchik No. 1650) was
Impregnated in an aqueous solution containing M sodium periodate, 200 mM borax-hydrochloric acid buffer (pH = 8.0),
It was dried with ventilation at 0°C for 50 minutes. Further, add 10 m of this filter paper.
Phenoxy ester compound shown in Table 1 of M, 10mM
It was impregnated with a chloroform solution containing 4-aminoantipyrine and 2% ethylene glycol monohexyl ether, and dried with ventilation at 40°C for 20 minutes. 5% 5mm
Cut into corners, drop a PBS suspension of 200 cells/μm granulocytes, and observe the color change after 1.5 minutes on 500 nm of the surface of the test paper.
The observation was made by measuring the reflected absorbance of m. The measurement was performed using MCPD-200 manufactured by Otsuka Electronics Co., Ltd.
5(5
1
表
(発明の効果)
以上述べたように、本発明による加水分解酵素測定器具
は、一般式Iで表わされるフェノキシエステル化合物、
顕色剤および酸化剤を吸着性担体に保持してなるもので
あるから、被検出物である加水分酵素に対して特異性が
高いため、良好な呈色性を示し、しかもなんら高価な装
置を必要とせずに、極めて簡単な操作で迅速に、しかも
高感度で測定できるという利点がある。5 (5 1 Table (Effects of the Invention)) As described above, the hydrolytic enzyme measuring instrument according to the present invention contains a phenoxyester compound represented by the general formula I,
Since it is made by holding a color developer and an oxidizing agent on an adsorbent carrier, it has high specificity for the hydrolytic enzyme that is the object to be detected, so it shows good color development and does not require any expensive equipment. It has the advantage of being able to perform measurements quickly, with extremely simple operations, and with high sensitivity, without the need for
Claims (8)
2〜5個からなるペプチド基、Bは窒素保護基、Xはハ
ロゲン原子、カルボキシル基、スルホン基またはチオア
ルキル基、R^1、R^2、R^3およびR^4は水素
原子、ハロゲン原子、アルキル基、アリール基、アルコ
キシ基、アシル基、アミド基、ニトロ基およびアルキル
チオール基よりなる群から選ばれたすくなくとも1種の
ものであり、R^1とR^2およびR^3とR^4とは
それぞれ縮合芳香環を形成していてもよい。)で表わさ
れるフェノキシエステル化合物、顕色剤および酸化剤を
吸着性担体に保持したことを特徴とする溶液中の加水分
解酵素用測定器具。(1) General formula I ▲Mathematical formulas, chemical formulas, tables, etc.▼(I) (In the formula, A is an amino acid residue or a peptide group consisting of 2 to 5 amino acid residues, B is a nitrogen protecting group, is a halogen atom, a carboxyl group, a sulfone group or a thioalkyl group, R^1, R^2, R^3 and R^4 are a hydrogen atom, a halogen atom, an alkyl group, an aryl group, an alkoxy group, an acyl group, an amide group, It is at least one type selected from the group consisting of a nitro group and an alkylthiol group, and R^1 and R^2 and R^3 and R^4 may each form a fused aromatic ring. 1. A measuring instrument for a hydrolase in a solution, characterized in that a phenoxy ester compound represented by (), a color developer, and an oxidizing agent are held in an adsorbent carrier.
剤が100〜20当量および酸化剤が500〜1,50
0当量配合されてなる請求項1に記載の測定器具。(2) 100 to 20 equivalents of color developer and 500 to 1,50 equivalents of oxidizing agent per 100 equivalents of the phenoxy ester compound
The measuring instrument according to claim 1, wherein 0 equivalent is blended.
ル−2−ベンゾチアゾリノンである請求項1に記載の測
定器具。(3) The measuring instrument according to claim 1, wherein the color developer is 4-aminoantipyrine or 3-methyl-2-benzothiazolinone.
、mは1〜3の整数であり、またnは1〜6の整数であ
る)で表わされる塩である請求項1に記載の測定器具。(4) The oxidizing agent has the general formula II ZY_mO_n(II) (wherein, Z is an alkali metal, Y is a halogen atom, m is an integer from 1 to 3, and n is an integer from 1 to 6) The measuring instrument according to claim 1, which is a salt represented by:
のいずれか一つに記載の測定器具。(5) Claims 1 to 4, wherein the adsorbent carrier is filter paper or fabric.
Measuring instruments described in any one of the above.
求項1〜5のいずれか一つに記載の測定器具。(6) The measuring instrument according to any one of claims 1 to 5, further comprising a surfactant or a wetting agent.
Hを有する緩衝剤を配合してなる請求項1〜6のいずれ
か一つに記載の測定器具。(7) P suitable for the reaction of the hydrolase that is the substance to be detected
The measuring instrument according to any one of claims 1 to 6, which contains a buffering agent containing H.
支持体に担持してなる溶液中の加水分解酵素用測定器具
。(8) A measuring device for a hydrolase in a solution, comprising the measuring device according to any one of claims 1 to 7 supported on a support.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP345690A JPH03210193A (en) | 1990-01-12 | 1990-01-12 | Measuring instrument for hydrolase |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP345690A JPH03210193A (en) | 1990-01-12 | 1990-01-12 | Measuring instrument for hydrolase |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH03210193A true JPH03210193A (en) | 1991-09-13 |
Family
ID=11557828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP345690A Pending JPH03210193A (en) | 1990-01-12 | 1990-01-12 | Measuring instrument for hydrolase |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH03210193A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008053390A1 (en) | 2006-10-30 | 2008-05-08 | Kimberly-Clark Worldwide, Inc. | Absorbent article containing lateral flow assay device |
WO2009074891A2 (en) | 2007-12-12 | 2009-06-18 | Kimberly-Clark Worldwide, Inc. | Resonance energy transfer based detection of nosocomial infection |
US8043272B2 (en) | 2007-04-30 | 2011-10-25 | Kimberly-Clark Worldwide, Inc. | Collection and testing of infant urine using an absorbent article |
US9895094B2 (en) | 2007-04-30 | 2018-02-20 | Kimberly-Clark Worldwide, Inc. | Lateral flow device for attachment to an absorbent article |
-
1990
- 1990-01-12 JP JP345690A patent/JPH03210193A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008053390A1 (en) | 2006-10-30 | 2008-05-08 | Kimberly-Clark Worldwide, Inc. | Absorbent article containing lateral flow assay device |
US8043272B2 (en) | 2007-04-30 | 2011-10-25 | Kimberly-Clark Worldwide, Inc. | Collection and testing of infant urine using an absorbent article |
US9895094B2 (en) | 2007-04-30 | 2018-02-20 | Kimberly-Clark Worldwide, Inc. | Lateral flow device for attachment to an absorbent article |
WO2009074891A2 (en) | 2007-12-12 | 2009-06-18 | Kimberly-Clark Worldwide, Inc. | Resonance energy transfer based detection of nosocomial infection |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CS245763B2 (en) | Agent for demonstration of proteolytical ferments | |
FI85990C (en) | SAMMANSAETTNING INNEHAOLLANDE ZWITTERJONKOPPLINGSMEDEL OCH TESTANORDNING FOER BESTAEMNING AV LEUKOCYTER. | |
CA1311333C (en) | Aminoluciferin derivatives, processes for the production thereof and their application in the determination of enzyme activities | |
JPS6145982B2 (en) | ||
NO164866B (en) | REAGENT AND INQUIRY DEVICE FOR DETERMINING THE PRESENCE OF LEUKOCYTES, ESTERASE AND PROTEASE IN A TEST. | |
EP0808458A1 (en) | Dioxetane compounds for the chemiluminescent detection of proteases, methods of use and kits therefore | |
US4645842A (en) | Pyrrole compounds for detecting the presence of hydrolytic analytes | |
EP0076042B1 (en) | Novel substrates for measuring thrombin | |
US4331760A (en) | Diagnostic agent for the detection of leukocytes and chromogens useful therein | |
US6180844B1 (en) | Composition containing fluorescence-generating substrate | |
JPS6245227B2 (en) | ||
JPH0610200B2 (en) | Chromogen amino acid ester and peptide ester, method for producing the same, and ester degrading and / or proteolytic enzyme detection reagent and method using these compounds | |
EP0277139B1 (en) | 7-amino-4-methyl-coumarin-3-carboxyalkyl derivatives and fluorescent conjugates thereof | |
JPH0784447B2 (en) | Dihydroresorufin compound, method for producing the same, and hydrolase measuring reagent containing the compound | |
JPH0873422A (en) | New amino acid ester and method for detecting leukocyte, esterase or protease | |
JPH03210193A (en) | Measuring instrument for hydrolase | |
US6140041A (en) | Fluorescent dye | |
EP0224254B1 (en) | a novel substrate for plasma kallikrein and a method for measuring biological components using the same | |
JPH03215462A (en) | Phenoxy ester compound, its production and detection of hydrolase using the same | |
JP2561928B2 (en) | Chromogenic compounds and methods for their production | |
JPH03244396A (en) | Detection of hydrolase and detection tool therefor | |
JPH01139564A (en) | N-substituted indole ester compound, production thereof, testing composition and testing tool using said compound | |
JP2896605B2 (en) | New peptide substrates, preparation methods and uses in protein C determination | |
JPH04103568A (en) | Thiophenol ester and device of measuring hydrolase using the same thiophenol ether | |
JPH03246285A (en) | Azoresorcinol ester derivative and hydrolase substrate |